Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 3, 2004, Pages 129-133

  Schroecksnadel, Katharina ^a   Leblhuber, Friedrich ^c   Frick, Barbara ^a   Wirleitner, Barbara ^a   Fuchs, Dietmar ^a,b,d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c KEPLER UNIVERSITY HOSPITAL   (Austria)

^d Institute of Biochemistry   (Austria)

Author keywords

Folate; Homocysteine; Neopterin; Soluble TNF receptor; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NEOPTERIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNE SYSTEM; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; IMMUNE SYSTEM; MALE; MIDDLE AGED; NEOPTERIN; REACTIVE OXYGEN SPECIES;

EID: 4444374420     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000127443.23312.31     Document Type: Article

References (36)

1. Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
2. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging. 2002;6:39-42.
3. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand. 1992;86:386-390.
4. Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol Biol Sci Med Sci. 1997;52:M76-M79.
5. McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 1998;13:235-239.
6. Riggs KM, Spiro A, Tucker K, et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996;63:306-314.
7. Smith AD. Homocysteine, B vitamins, and cognitive deficit in the elderly. Am J Clin Nutr. 2002;75:785-786.
8. Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449-1455.
9. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
10. Gottfries J, Blennow K, Lehmann MW, et al. One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis. J Geriatr Psychiatry Neurol. 2001;14:109-114.
11. Leblhuber F, Walli J, Artner-Dworzak E, et al. Hyperhomocysteinemia in dementia. J Neural Transm. 2000;107:1469-1474.
12. McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging. 2001;22:799-809.
13. Owen AD, Schapira AH, Jenner P, et al. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies. J Neural Transm Suppl. 1997;51:167-173.
14. Rogers J, Webster S, Lue LF, et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging. 1996;17:681-686.
15. Leblhuber F, Walli J, Demel U, et al. Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin Chem Lab Med. 1999;37:429-431.
16. Hull M, Pasinelti GM, Aisen PS. Elevated plasma neoplerin levels in Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14:228-230.
17. Licastro F, Pedrini S, Caputo L, et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1- antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol. 2000;103:97-102.
18. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
19. Frick B, Schroecksnadel K, Neurauter G, et al. Rapid measurement of total plasma homocysteine by HPLC. Clin Chim Acta. 2003;331:19-23.
20. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999;131:331-339.
21. Fuchs D, Weiss G, Reibnegger G, et al. Neopterin: the role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit Rev Clin Lab Sci. 1992;29:307-341.
22. Burtis CA, Ashwood ER. In: Tietz, ed. Textbook of Clinical Chemistry, 2nded. Philadelphia: Saunders; 1994:2057.
23. Frenkel EP, White JD, Reisch JS, et al. Comparison of two methods for radioassay of vitamin B12 in serum. Clin Chem. 1994;40:537-540.
24. Kern P, Hemmer CJ, Gallati H, et al. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis. 1992;166:930-934.
25. Gordon MN. Mieroglia and immune activation in Alzheimer's disease. J Fla Med Assoc. 1993;80:267-270.
26. Murr C, Fuith LC, Widner B, et al. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 1999;19:1721-1728.
27. Widner B, Baier-Bitterlicli G, Wede I, et al. Neopterin: indicator of oxidative stress and part of the cytotoxic armature of activated macrophages in humans. Pteridines. 1998;9:91-102.
28. Powers RW, Evans RW, Majors AK. et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol. 1998;179:1605-1611.
29. Gottsater A, Anwaar I, Eriksson KF, et al. Homocysteine is related to neopterin and endothelin-1 in plasma of subjects with disturbed glucose metabolism and reference subjects. Angiology. 2000;51:489-497.
30. Widner B, Leblhuber F, Frick B, et al. Moderate hyperhomocysteinemia and immune activation in Parkinson's disease. J Neural Transm. 2002;109:1445-1452.
31. Schroecksnadel K, Frick B, Wirleitner B, et al. Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Clin Exp Immunol. (in press)
32. Odin E, Carlsson G, Frosing R, et al. Chemical stability and human plasma pharmacokinetics of reduced folates. Cancer Invent. 1998;16:447-455.
33. McCaddon A, Regland B, Hudson P, et al. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology. 2002;58:1395-1399.
34. Fuchs D, Jaeger M, Widner B, et al. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin Chem Lab Med. 2001;39:691-694.
35. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;31;354:407-413.
36. White AR, Huang X, Jobling MF, et al. Homocysteine potentiates copper-and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem. 2001;76:1509-1520.